Grant Programs for Scientific Projects in the Field of Cystic Fibrosis (CF)

Mukoviszidose e.V. provides funding exclusively for projects in the sector of CF contributing significantly to patient-relevant therapeutic progress. This includes research translating findings from basic CF-related research into the development of specific diagnostic or therapeutic applications (translational research), pre-clinical development projects and clinical research. Funding of basic-science without any application perspective is not within the scope of the funding scheme.

We actively encourage co-operation between basic-research scientists and clinicians in developing new diagnostic and therapeutic options.

Grant programs available are: Focus funding in special subject areas, start-up support and young-investigator grants.

Special subject areas are:

  • Clinical trials to improve diagnosis and therapy of chronic infections of the respiratory tract, of disturbances in growth and development and of related secondary diseases (e.g. diabetes, osteoporosis, liver complaints)
  • Compensation of the basic defect by way of substances that reinforce the residual function of CFTR and/or regulate alternative ion channels
  • Development of new anti-infective and anti-inflammatory drugs
  • Development of animal models

In addition, this time, grant applications concerning the clinical relevance of culture-independent methods for microbiological diagnostics in cystic fibrosis are particularly encouraged.

For more information on special subject areas please see the application manual “Notes for Applicants”.
The total amount of financial support for new applications for a two year period (2010 to 2012) will be
2.0 million Euro

The evaluation process for applications is administered by Mukoviszidose Institute gGmbH (MI), Bonn, the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V. and consists of two steps:
submission of a project outline as an initial application (step I) and - if evaluated positively by our research board (Board of FGM, the German Research Community for CF) - submission of a detailed application (step II) which is subject to an external per-review process.

Deadline for handing in initial applications (step I) is:
Mukoviszidose e.V., In den Dauen 6, 53117 Bonn
31. December 2010
For further information please see the „Notes for Applicants“ or our website http://www.cf-germany.org/ (Support of Cf-related research).

If you have any questions, please do not hesitate to contact the MI-team:
Dr. Sylvia Hafkemeyer (shafkemeyer@muko.info; Tel.: 0228-9878042)
Dr. Jutta Bend (jbend@muko.info; Tel.: 0228-9878047).